Abstract
Psoriasis is a chronic inflammatory, proliferative skin disease characterized by pathological skin lesions due to various exogenous and endogenous factors. It is associated with a number of biochemical and immunological disturbances. Recently, it has been suggested that increased reactive oxygen species (ROS) production and compromised function of antioxidant system may be involved in the pathogenesis of this disease. In the present study, 90 psoriasis patients were selected. Disease severity was assessed by psoriasis area severity index score and grouped as mild, moderate and severe (each group consists of 30 subjects) and compared with 30 healthy controls. Serum levels of malondialdehyde, nitric oxide end products and the activities of antioxidant enzymes such as erythrocyte-superoxide dismutase, catalase and total antioxidant status were investigated in these groups/subjects. As compared to controls, we found severitywise significantly increased serum malondialdehyde, nitric oxide end products with decrease in erythrocyte-superoxide dismutase activity, catalase activity and total antioxidant status in patients with psoriasis suggesting worsening of the disease. It seems to be linked with the enhancement of Reactive Oxygen Species production and decreased antioxidant potential in psoriasis.
Similar content being viewed by others
References
Wozniak A, Drewa G, Krzyzynka-Malinowska E, Czajkowski R, Protas-Drozd F, Mila-Kierzenkowska C, et al. Oxidant antioxidant balance in patients with psoriasis. Med Sci Monit. 2007;13(1):R 30–3.
Vanizor KB, Orem A, Cimsit G, Yandi YE, Calapoglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationship with oxidant–antioxidant system in patients with psoriasis. Clin Chim Acta. 2003;328(1–2):71–82.
Luty-Frackiwicz A, Gorka IM, Januszewska L. Influence of smoking and alcohol consumption on total antioxidant status in patients with psoriasis. Adv Clin Exp Med. 2006;15(3):463–9.
Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002;29:399–403.
Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases—what’s new? JEADV. 2003;17:663–9.
Corrocher R, Ferrari S, Gironcoli M, Bassi A, Olivieri O, Guarini P, et al. Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis. Clin Chim Acta. 1989;179:121–32.
Cals-Grierson MM, Ormerod AD. Nitric oxide functions in the skin. Nitric Oxide. 2004;10(4):179–93.
Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antoxidants in epidermis and dermis of human skin. J Investig Dermatol. 1994;102:122–4.
Langseth L. Oxidants, antioxidants and disease prevention. International Life Sciences Institute and ILSI Europe; 1995. p. 1–32.
Baz K, Cimen MYB, Kokturk A, Yazici AC, Eskandari G, Ikizoglu G, et al. Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J. 2003;44(6):987–90.
Louden BA, Pearce DJ, Lang W, Feldman SR. A simplified psoriasis area severity index (SPASI) for rating psoriasis severity in clinical patients. Dermatol Online J. 2004;10(2):7.
Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.
Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium reduction method. Clin Chem. 1990;36(8):1440–3.
Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196:143–52.
Das K, Samanta L, Chainy GBN. A modified spectrophotometric assay of superoxide dismutase using nitrite formation by superoxide radicals. Indian J Biochem Biophys. 2000;37:201–4.
Benzie IFF, Strain JJ. The ferric reducing ability of plasma [FRAP] as a measure of ‘antioxidant power’ the FRAP assay. Anal Biochem. 1996;239:70–6.
Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta. 2007;380:50–8.
Yildirim M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. JEADV. 2003;17:34–6.
Popov I, Lewin G. A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses. 1991;35:229–36.
Miyachi Y, Niwa Y. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes. Arch Dermatol Res. 1983;275:23–6.
Turner CP, Toye AM, Jones OTG. Keratinocyte superoxide generation. Free Radic Biol Med. 1998;24(3):401–7.
Raynaud F, Evain-Brion D, Gerbaud P, Marciano D, Gorin I, Liapi C, et al. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Radic Biol Med. 1996;22(4):623–32.
Hristakieva E, Gadjeva V. Seasonal variations in the activity of antioxidant enzymes and lipid peroxidation in psoriatic and vitiligo patients. Trakia J Sci. 2003;1(1):27–31.
Dimon-Gadal S, Gerbaud P, Therond P, Guibourdenche J, Anderson WB, Evain-Brion D, et al. Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J Investig Dermatol. 2000;114:984–9.
Tekin NS, Ilter N, Sancak B, Ozden MG, Gurer MA. Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediat Inflamm. 2006;16043l:1–5.
Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998;41(7):1141–51.
Kolb-Bachofen V, Fehsel K, Michel G, Ruzicka T. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of Psoriasis vulgaris. Lancet. 1994;344:139.
Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowksi P, et al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res. 1998;290:3–8.
Sirsjo A, Karlsson M, Gidof A, Rollman O, Torma H. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol. 1996;134(4):643–8.
Orem A, Aliyazicioglu R, Kiran E, Vanizor B, Cimnocodeit G, Deger O. The relationship between nitric oxide production and activity of the disease in patients with psoriasis. Arch Dermatol. 1997;133:1606–7.
Ilzuka H, Asaga H, Koike K, Ilzuka S. Decreased Cu, Zn-superoxide dismutase activity in psoriatic hyperproliferative epidermis. Eur J Dermatol. 1993;3:56–8.
Kobayashi T, Matsumoto M, Ilzuka H, Suzuki K, Taniguchi N. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: an immunohistochemical study. Br J Dermatol. 1991;124(6):555–9.
Gornicki A, Gutsze A. Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J Dermatol Sci. 2001;27:27–30.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kadam, D.P., Suryakar, A.N., Ankush, R.D. et al. Role of Oxidative Stress in Various Stages of Psoriasis. Ind J Clin Biochem 25, 388–392 (2010). https://doi.org/10.1007/s12291-010-0043-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-010-0043-9